Scilex Holding Co (SCLX)

Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 4 signals for Scilex Holding Co. Most notable: 2026-07-22: Filed 8-K disclosing material agreement, acquisition or disposition of assets; 2026-06-29: Filed 8-K disclosing material agreement; 2026-07-06: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement
  2. Material 8-K filing
    Filed 8-K disclosing material agreement, acquisition or disposition of assets
  3. Material 8-K filing
    Filed 8-K disclosing material agreement
  4. Material 8-K filing
    Filed 8-K disclosing material agreement
  5. Material 8-K filing
    Filed 8-K disclosing material agreement
  6. Material 8-K filing
    Filed 8-K disclosing material agreement
  7. Material 8-K filing
    Filed 8-K disclosing material agreement
  8. Material 8-K filing
    Filed 8-K disclosing material agreement
  9. Large insider sale
    Scilex Holding Co (ten_percent_owner) sold $5.2M of stock
  10. Large insider sale
    Scilex Holding Co (ten_percent_owner) sold $4.8M of stock
  11. Large insider sale
    Scilex Holding Co (ten_percent_owner) sold $2.8M of stock
  12. Material 8-K filing
    Filed 8-K disclosing material agreement
  13. Material 8-K filing
    Filed 8-K disclosing material agreement
  14. Material 8-K filing
    Filed 8-K disclosing director or officer change
  15. Material 8-K filing
    Filed 8-K disclosing material agreement
  16. Material 8-K filing
    Filed 8-K disclosing acquisition or disposition of assets
  17. Material 8-K filing
    Filed 8-K disclosing material agreement
  18. Material 8-K filing
    Filed 8-K disclosing material agreement
  19. Material 8-K filing
    Filed 8-K disclosing director or officer change
  20. Material 8-K filing
    Filed 8-K disclosing material agreement
  21. Material 8-K filing
    Filed 8-K disclosing material agreement, acquisition or disposition of assets
  22. Material 8-K filing
    Filed 8-K disclosing material agreement, acquisition or disposition of assets
  23. Material 8-K filing
    Filed 8-K disclosing director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2025-12-30Scilex Holding Coten percent ownerS9,657,3000.54$5,214,942
2025-12-29Scilex Holding Coten percent ownerS7,310,9840.66$4,825,249
2025-12-26Scilex Holding Coten percent ownerS3,689,0160.75$2,766,762
2025-01-21SCLX Stock Acquisition JV LLCten percent ownerJ3,250,000——
2025-01-16SCLX Stock Acquisition JV LLCten percent ownerJ779,371——
2025-01-02SCLX Stock Acquisition JV LLCten percent ownerJ5,000,000——
2024-12-18SHAH JAISIMdirectorP30,0000.46$13,800
2024-10-31Ji HenrydirectorP8,8880.94$8,355
2024-10-29SHAH JAISIMdirectorP32,0000.99$31,680
2024-10-18Chun JaydirectorP5,0000.95$4,750
2024-10-18Followwill DormandirectorP1,0000.99$990
2024-10-17Ji HenrydirectorP10,0000.97$9,700
2024-10-17Lemus DaviddirectorP2,0000.9$1,800
2024-10-17Wu Yue AlexanderdirectorP20,0000.95$19,000
2024-10-16Ma Stephen HoiofficerP6,7000.97$6,499
2024-10-16SHAH JAISIMdirectorP30,0000.99$29,700

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings